Lunai Bioworks (LNAI) Accounts Payables (2011 - 2026)

Lunai Bioworks' Accounts Payables history runs 16 years deep, the most recent figure standing at $12.7 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 8.09% year-over-year to $12.7 million; the TTM figure through Mar 2026 stood at $12.7 million (up 8.09% YoY), while the FY2025 annual figure was $12.6 million, up 32.88% from the prior year.
• Accounts Payables was $12.7 million for Q1 2026 at Lunai Bioworks, up from $12.3 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $12.7 million in Q1 2026 to a low of $487016.0 in Q1 2022.
• Historically, Accounts Payables has averaged $7.8 million across 5 years, with a median of $8.0 million in 2024.
• Biggest YoY gain for Accounts Payables was 2631.77% in 2022; the steepest drop was 3.53% in 2022.
• A 5-year view of Accounts Payables shows it stood at $4.6 million in 2022, then grew by 22.45% to $5.6 million in 2023, then jumped by 96.03% to $10.9 million in 2024, then advanced by 12.85% to $12.3 million in 2025, then rose by 2.72% to $12.7 million in 2026.
• The last three Accounts Payables figures came in at $12.7 million (Q1 2026), $12.3 million (Q4 2025), and $12.1 million (Q3 2025), per Business Quant data.